Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 610,483,840
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 33,724 M
  • Annual Income, $ 12,151 M
  • 60-Month Beta 0.43
  • Price/Sales 18.05
  • Price/Cash Flow 45.18
  • Price/Book 42.39
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 26.18% ( +2.09%)
  • Historical Volatility 23.48%
  • IV Percentile 26%
  • IV Rank 16.51%
  • IV High 44.88% on 08/03/23
  • IV Low 22.48% on 06/13/23
  • Put/Call Vol Ratio 0.64
  • Today's Volume 14,027
  • Volume Avg (30-Day) 21,530
  • Put/Call OI Ratio 0.70
  • Today's Open Interest 242,796
  • Open Int (30-Day) 260,893

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.83
  • Number of Estimates 3
  • High Estimate 0.85
  • Low Estimate 0.82
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +31.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.29 +10.54%
on 05/03/24
137.22 -2.29%
on 05/23/24
+7.23 (+5.70%)
since 04/26/24
3-Month
118.91 +12.76%
on 02/29/24
138.28 -3.04%
on 03/07/24
+12.54 (+10.32%)
since 02/28/24
52-Week
75.56 +77.45%
on 07/11/23
138.28 -3.04%
on 03/07/24
+52.60 (+64.55%)
since 05/26/23

Most Recent Stories

More News
A New Name in Weight Loss Drugs

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

HIMS : 19.10 (+13.15%)
NVO : 134.08 (-1.44%)
LLY : 807.86 (+0.05%)
XPOF : 9.50 (+4.40%)
WIX : 165.06 (-2.91%)
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?

Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.

NVO : 134.08 (-1.44%)
BMO : 96.11 (+0.67%)
CTLT : 54.00 (-1.50%)
HIMS : 19.10 (+13.15%)
LLY : 807.86 (+0.05%)
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?

The gold rush for obesity medications just got a bit more intense.

AMGN : 300.19 (-1.85%)
LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
Where Will Novo Nordisk Be in 10 Years?

Will Novo Nordisk top $1 trillion in market value?

LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
3 High-Flying Stocks That Could Soar Even More

The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.

LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
VRTX : 446.88 (-2.20%)
Is Hims & Hers Stock a Buy for GLP-1 Upside?

Hims & Hers is a digital health company that is firing on all cylinders, while improving its profit margins at a robust pace.

HIMS : 19.10 (+13.15%)
LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
Novo Nordisk's Stock Dips After Second Fire Hits Danish Facilities

Novo Nordisk (NVO), the maker of popular weight-loss and diabetes treatments Ozempic and Wegovy, experienced a significant fire at its Danish headquarters in Bagsvaerd, marking the second blaze to impact...

NVO : 134.08 (-1.44%)
Is Novo Nordisk Stock a Millionaire Maker?

Novo Nordisk's stock may look expensive today, but that may not be the case in even a year or two.

NVO : 134.08 (-1.44%)
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk

Could Amgen be the next stock to soar due to a GLP-1 drug?

NVO : 134.08 (-1.44%)
LLY : 807.86 (+0.05%)
AMGN : 300.19 (-1.85%)
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today

Back then, the company wasn't very well known to U.S. investors. That's absolutely not the case these days.

NVO : 134.08 (-1.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 136.77
2nd Resistance Point 135.68
1st Resistance Point 134.88
Last Price 134.08
1st Support Level 132.99
2nd Support Level 131.90
3rd Support Level 131.10

See More

52-Week High 138.28
Last Price 134.08
Fibonacci 61.8% 114.32
Fibonacci 50% 106.92
Fibonacci 38.2% 99.52
52-Week Low 75.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar